A detailed history of Graham Capital Management, L.P. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 15,022 shares of PLRX stock, worth $228,184. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,022
Holding current value
$228,184
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.58 - $15.61 $158,932 - $234,493
15,022 New
15,022 $161,000
Q2 2022

Aug 15, 2022

BUY
$4.11 - $8.75 $41,930 - $89,267
10,202 New
10,202 $81,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $739M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.